Infectious Disease
RSSArticles
-
VIRSTA vs. PREDICT: Which Is Best for Anticipating Endocarditis?
Researchers in Columbia put predictive scoring methods through their paces.
-
Importance of Exercise Testing-Associated Ventricular Ectopy
A study of asymptomatic subjects without known cardiovascular disease undergoing treadmill exercise testing and followed for a mean of 20 years showed high-grade premature ventricular contractions during exercise recovery (but not during exercise) are predictive of subsequent cardiovascular mortality.
-
Herpes Simplex Virus 2 Meningitis in Adults
The incidence of herpes simplex virus 2 meningitis in adults in Denmark over a six-year period was 0.7/100,000 population per year, with 91% of cases occurring in the absence of immunocompromise.
-
CABG Wins Again for Multivessel Disease
Fractional flow reserve-guided percutaneous coronary intervention failed to meet noninferiority guidelines vs. coronary artery bypass grafting.
-
Coronary Calcium Score Zero: Are You Home Free?
Among those with a coronary calcium score of 0 after a median follow-up of 16 years, current cigarette smoking, diabetes, and hypertension were independently associated with the development of atherosclerotic cardiovascular disease.
-
Long-Term Care Facilities Cut Superfluous Antibiotic Use
Locations that adhered to federal safety program reported more success in this area.
-
Understanding Each COVID-19 Test’s Strengths and Weaknesses
Considering that testing over multiple days is not practical in the ED, clinicians with access to relatively rapid RT-PCR testing probably will opt for the more sensitive test. However, the antigen test offers a good option to urgent care centers or EDs that lack access to a sophisticated lab.
-
How Many Leads Are Abnormal?
The figure was obtained after cardiac catheterization for new chest pain. The rhythm is sinus bradycardia at ~50 beats/minute. All intervals are normal. The axis is leftward, but not enough to qualify as a hemiblock. There is no chamber enlargement.
-
Abrocitinib Tablets/Upadacitinib Extended-Release Tablets (Cibinqo/Rinvoq)
Abrocitinib and upadacitinib can be prescribed to treat adults with refractory, moderate-to-severe atopic dermatitis that is not adequately controlled with other systemic drug products, including biologics, or when using those therapies is inadvisable.
-
Booster Doses Effective Against Omicron
While vaccination provides protection against infection with omicron variant of SARS-CoV-2, high level protection from a need for hospitalization requires a booster dose.